GlassScriptPhysician profile
Jeffery A Tinker
NPI 1871787184
$2,620.59
in general payments reported to CMS, 2019-2025
24 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $460 · 2022: $615 · 2023: $596 · 2024: $405 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,546.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $344.99 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $321.62 | 2021-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $304.70 | 2023-2024 | Fms Duo, Healix Knotless Peek, Peak |
| Stryker Corporation | $278.60 | 2021-2022 | |
| Orthofix Medical, INC. | $225.11 | 2022-2023 | Physio-Stim, Spinal-Stim |
| Djo, LLC | $222.97 | 2024-2025 | Cmf |
| Curonix LLC | $205.10 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Music City Medical Technologies, LLC | $180.53 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $72.97 | 2024-2025 | |
| Avanos Medical | $70.02 | 2022 | |
| Medtronic, INC. | $64.06 | 2023-2024 | Intellis Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $50.40 | 2023-2025 | Iovera, Zilretta, Exparel |
| Fidia Pharma USA INC. | $46.03 | 2023-2024 | Triluron, Hymovis, Hyalgan |
| Smith+Nephew, INC. | $40.59 | 2023 | Grafix, Stravix |
| Triad Life Sciences INC. | $31.99 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $27.30 | 2025 | Onpattro |
| Integra Lifesciences Corporation | $20.35 | 2022 | |
| Amneal Pharmaceuticals LLC | $19.12 | 2023 | Lyvispah |
| Convatec INC. | $18.95 | 2023 | |
| Zimmer Biomet Holdings, INC. | $18.39 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Nevro Corp. | $16.10 | 2024 | Senza |
| Paragon 28, INC. | $15.45 | 2022 | |
| Pacira Therapeutics, INC. | $13.87 | 2021 | |
| Orthogenrx INC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Tinker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.